A Phase Ⅲ Clinical Study Trial of Felbinac Trometamol Injection in China

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
A multi-center, randomized, double-blind, placebo parallel controlled phase Ⅲ clinical trial on the efficacy and safety of felbinac trometamol Injection in the treatment of moderate and severe postoperative pain.main purpose is to evaluate the efficacy of Felbinac Trometamol Injection in the treatment of moderate and severe pain after surgery.Secondary purpose is to evaluation the safety of Felbinac Trometamol Injection in the treatment of moderate and severe pain after surgery.
Epistemonikos ID: 9c3eebdc2ec632d846fd647aa1df4a959520d24f
First added on: May 07, 2024